id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-348786-25o7tam4	Mella, Alberto	Case series of six kidney transplanted patients with COVID‐19 pneumonia treated with tocilizumab	2020-06-17		.txt	text/plain	1501	88	39	We report our case series of 6 KTs with COVID‐19 pneumonia who received TCZ: All were of male gender, with a mean age of 55.5 ± 8.4 years, a median time from transplantation of 3611 days (1465‐5757); 5/6 had cardiovascular comorbidities, 1/6 had diabetes, and 3/6 have one or more previous KTs. Four out of six patients died, at an average time of 9.75 ± 2.4 days after tocilizumab administration, 3/6 due to a coexistent septic shock. Ongoing immunosuppressive therapy was composed by TAC and TA B L E 2 Laboratory and pulmonary functional tests before and after TCZ adoption in our COVID-19-positive kidney transplant recipients To date, few reports included TCZ-treated kidney transplanted patients with COVID-19 pneumonia 12,19-23 ( other Authors, the virus caused a profound immunosuppression 5, 11 and, in this context, the result of combined inhibition of IL-6 receptor in predisposing to bacterial infections is not well understood.	./cache/cord-348786-25o7tam4.txt	./txt/cord-348786-25o7tam4.txt